Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Smo

Smoothened (Smo), a class Frizzled G protein-coupled receptor (class F GPCR), transduces the Hedgehog (Hh) signal across the cell membrane. The Hh signaling pathway includes both canonical and noncanonical pathways. The canonical Hh pathway functions through major Hh molecules such as Hh ligands, PTCH, Smo, and GLI, whereas the noncanonical Hh pathway involves the activation of Smo or GLI through other pathways. The Hh signaling cascade is initiated by the binding of the Hh protein ligand to its cellular membrane receptor, Patched (PTCH), which relieves PTCH-mediated repression of the seven-transmembrane (7TM) protein Smo. Activated Smo transduces the signal to the GLI family of transcription factors, which translocate to the nucleus to regulate numerous gene products involved in tissue patterning and cell differentiation.

SAG
T1779912545-86-9
SAG (Smoothened Agonist) is a Smo receptor agonist (EC50=3 nM) that is cell-permeable and selective. SAG regulates Smo activity by binding directly to the Smo helix and can activate the Hedgehog signaling pathway.
  • 44 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Jervine
T3363469-59-0
The biological activity of Jervine (Jerwiny) is mediated via its interaction with the 7 passes transmembrane protein Smoothened. Jervine binds with and inhibits smoothened, which is an integral part of the Hedgehog signaling pathways. With smoothened inhibited, the GLI1 transcription cannot be activated and Hedgehog target genes cannot be transcribed.
  • 60 €
In Stock
Size
QTY
Purmorphamine
T1810483367-10-8
Purmorphamine (Shh Signaling Antagonist VI), which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo. It also is an inducer of osteoblast differentiation.
  • 48 €
In Stock
Size
QTY
TargetMol | Citations Cited
SANT-1
T2450304909-07-7
SANT-1 directly binds to Smoothened (Smo) receptor (Kd: 1.2 nM) and inhibits Smo agonist effects (IC50: 20 nM).
  • 28 €
In Stock
Size
QTY
TargetMol | Citations Cited
Cyclopamine
T28254449-51-8
Cyclopamine (11-Deoxojervine), a Smoothened (Smo) antagonist (IC50: 46 nM in TM3Hh12 cells), belongs to the group of steroidal jerveratrum alkaloids.
  • 45 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
20(S)-Hydroxycholesterol
T10085516-72-3In house
20(S)-Hydroxycholesterol (20α-Hydroxycholesterol) is an allosteric activator of the oncoprotein smoothened (Smo).
  • 28 €
In Stock
Size
QTY
Glasdegib
T65141095173-27-5
Glasdegib (PF-04449913) (PF-04449913) is a potent, and orally bioavailable Smoothened (Smo) inhibitor with IC50 of 5 nM. Phase 2.
  • 34 €
In Stock
Size
QTY
LEQ506
T118381204975-42-7In house
LEQ506 is a Smo inhibitor with IC50s of 2 nM and 4 nM for hSmo and mSmo, respectively.
  • 55 €
In Stock
Size
QTY
Sonidegib
T1926956697-53-3
Sonidegib (Erismodegib), a Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human), respectively.
  • 51 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Halcinonide
T01073093-35-4
Halcinonide (Halciderm), a high-efficiency corticosteroid, is served as an anti-inflammatory agent used in topical preparations.
  • 38 €
In Stock
Size
QTY
Taladegib
T26661258861-20-9
Taladegib (LY2940680) is an orally bioavailable small molecule antagonist of the Hedgehog (Hh)-ligand cell surface receptor smoothened (Smo) with potential antineoplastic activity.
  • 33 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
DY131
T225095167-41-2
DY131 (DY-131) is a novel selective agonist of ERRβ and ERRγ.
  • 44 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BMS-833923
T22991059734-66-5
BMS-833923 (XL-139), an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
  • 43 €
In Stock
Size
QTY
PF-5274857
T54651373615-35-0
PF-5274857 (PF-5274857 free base) is an effective and selective hedgehog signaling pathway inhibitor (IC50: 5.8 nM and a Ki: 4.6 nM). PF-5274857 is a potentially attractive clinical candidate for the treatment of tumor types including brain tumors and brain metastasis driven by an activated Hh pathway.PF-5274857 was found to effectively penetrate the blood-brain barrier and inhibit Smo activity in the brain of primary medulloblastoma mice, resulting in improved animal survival rates. PF-5274857 was orally available and metabolically stable in vivo.
  • 28 €
In Stock
Size
QTY
Sonidegib diphosphate
T157271218778-77-8
Sonidegib diphosphate (LDE225 diphosphate) is a selective antagonist of Smo that inhibits murine Smo (IC50:1.3 nM) and human Smo (IC50:2.5 nM).
  • 40 €
In Stock
Size
QTY
AZD8542
T267231126366-36-6
AZD8542 is an antagonist of Smoothened (SMO) with potential as an [oncology therapeutic].
  • 316 €
In Stock
Size
QTY
GI-560192
T64351301326-41-0
GI-560192 (RL-0070933) is a potent smo cilial modulator with an EC50 value of 0.02 µM. GI-560192 modulates the translocation and or accumulation of smoothened to the primary cilia by hedgehog signaling pathway.
  • 111 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
HhAntag
T3460496794-70-8
HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.
  • 59 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
MRT-14
T95311263131-83-4
MRT-14 is a potent Smo antagonist and can be used in several types of cancers linked to abnormal Hh signaling studies.
  • 28 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MK-4101
T6891935273-79-3
MK-4101, an effective inhibitor of the Hedgehog pathway, has anti-tumor activity through the induction of extensive apoptosis and inhibition of proliferation in tumor cells.
  • 29 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ALLO-2
T141881357350-60-7
ALLO-2 is a Inhibitor of Drug-Resistant Smo Mutant.It inhibits Smo agonist Hh-Ag1.5-induced luciferase expression in TM3-Gli-Luc cells with IC50 of 6 nM.
  • 55 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
IHR-1
T24159548779-60-8
IHR-1 is a Potent Smo antagonist (IC50 = 7.6 nM). Selectively inhibits Hedgehog signaling over Wnt and Notch signaling pathways. Blocks Smo accumulation in primary cilium in vitro.
  • 27 €
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MRT-83
T121091263131-92-5
MRT-83 is a potent Smo antagonist.
  • 36 €
In Stock
Size
QTY
JNJ-1289
T60738792898-18-1
JNJ-1289 is a selective, potent, and competitive inhibitor of human spermine oxidase (hSMOX) with an IC50 value of 50 nM.JNJ-1289 has potential anticancer and anti-inflammatory activity for the study of polyamine catabolic disorders.
  • 188 €
In Stock
Size
QTY
MRT-92
T2000331428315-82-5
MRT-92 is an antagonist of Smoothened (Smo) with anti-cancer activity, featuring a binding affinity (Ki) of 0.7 nM. It inhibits the Hedgehog signaling pathway by obstructing the overlapping binding sites within the transmembrane domain of the Smoothened receptor and suppresses the proliferation of cerebellar granule cells in rodents (IC50=0.4 nM). MRT-92 is utilized for research into cerebellar gliomas.
  • Inquiry Price
10-14 weeks
Size
QTY